RSF1 Antibody

What is RSF1 and what are its primary functions in chromatin biology?

RSF1 (Remodeling and spacing factor 1) serves as the regulatory subunit of ATP-dependent chromatin remodeling complexes known as RSF-1 and RSF-5 ISWI. These complexes play critical roles in forming ordered nucleosome arrays on chromatin, thereby facilitating access to DNA during fundamental cellular processes including DNA replication, transcription, and repair mechanisms . RSF1 binds to core histones in conjunction with SMARCA5, a partnership essential for the assembly of regular nucleosome arrays by the RSF-5 ISWI chromatin-remodeling complex . Beyond structural organization, RSF1 directly stimulates the ATPase activity of both SMARCA1 and SMARCA5 within their respective chromatin-remodeling complexes . Interestingly, the RSF-1 ISWI complex exhibits a lower ATP hydrolysis rate compared to the RSF-5 ISWI complex, suggesting functional specialization between these related molecular machines .

How does RSF1 contribute to viral gene expression regulation?

RSF1 exhibits significant functionality in viral contexts, particularly with hepatitis B virus (HBV). Research demonstrates that RSF1 facilitates transcription of HBV genes through interaction with the pX transcription activator . During HBV infection, RSF1 works cooperatively with pX to repress TNF-alpha induced NF-kappa-B transcription activation, suggesting an immunomodulatory role during viral infection . Additionally, RSF1 has been shown to repress transcription when artificially recruited to chromatin through fusion with heterogeneous DNA binding domains . These viral interaction capabilities highlight RSF1's potential significance beyond normal cellular processes, positioning it at the interface of host-pathogen molecular interactions and potentially offering therapeutic targets for intervention in viral diseases.

What are the alternative names and identifiers for RSF1 in scientific literature?

When conducting literature searches or database queries for RSF1, researchers should be aware of its multiple nomenclature variants. The protein is variously referred to as HBXAP, XAP8, Rsf-1, HBV pX-associated protein 8, Hepatitis B virus X-associated protein, and p325 subunit of RSF chromatin-remodeling complex . These diverse designations reflect the protein's discovery in different biological contexts and by different research groups. Understanding these alternative identifiers is crucial for comprehensive literature reviews and database mining, ensuring that researchers access the complete body of knowledge regarding this multifunctional protein and its antibodies.

What applications are RSF1 antibodies validated for in laboratory research?

RSF1 antibodies have been validated for multiple experimental applications essential to molecular and cellular biology research. Based on commercial antibody specifications and research publications, these antibodies are suitable for immunohistochemistry on paraffin-embedded tissues (IHC-P), Western blotting (WB), immunocytochemistry/immunofluorescence (ICC/IF), and intracellular flow cytometry (Flow Cyt Intra) . The recombinant monoclonal format ensures consistency between batches, while the rabbit host species provides advantages in terms of sensitivity and specificity for human samples . When selecting an RSF1 antibody for research, prioritize antibodies with application-specific validation data and citation records demonstrating successful use in peer-reviewed publications, as these provide confidence in experimental reliability and reproducibility.

How should co-immunoprecipitation experiments be designed to study RSF1 protein interactions?

Co-immunoprecipitation (co-IP) experiments for RSF1 require careful optimization due to the protein's dynamic interactions that change based on cellular conditions. Research indicates that RSF1's binding partners vary significantly depending on microtubule attachment status . For example, in nocodazole-arrested cells (microtubule depolymerization), RSF1 predominantly associates with histone H3 and Aurora B, while in paclitaxel-arrested cells (microtubule stabilization), it preferentially binds to BubR1 at kinetochores .

When designing co-IP experiments:

• Consider cell synchronization protocols to capture specific cell cycle phases

• Include appropriate positive controls for each anticipated interaction partner

• Validate antibody specificity using knockout or knockdown controls

• Use gentle lysis conditions to preserve native protein complexes

• Include DNase/RNase treatments to distinguish direct protein interactions from nucleic acid-mediated associations

The dynamic redistribution of RSF1 between centromeres and kinetochores requires careful experimental timing and cellular synchronization to accurately capture the intended protein-protein interactions.

What are the best practices for immunofluorescence studies targeting RSF1?

Immunofluorescence experiments studying RSF1 require specific technical considerations due to its dynamic localization patterns during cell cycle progression. When planning these studies:

• Cell fixation method is critical - paraformaldehyde (4%) preserves protein structures while maintaining antigen accessibility

• Include co-staining with established centromeric/kinetochore markers (e.g., Aurora B, CENP proteins) to provide spatial context

• Employ confocal microscopy for superior resolution of the centromere/kinetochore region

• Use synchronized cell populations to capture specific mitotic phases

• Include microtubule-targeting drug treatments (nocodazole or paclitaxel) to study attachment-dependent localization changes

Research demonstrates that RSF1 shows differential positioning relative to Aurora B depending on microtubule attachment status . Under nocodazole treatment (microtubule depolymerization), RSF1 localizes adjacent to Aurora B, while in paclitaxel-arrested cells (microtubule stabilization), two RSF1 spots appear separated by centromeric Aurora B . This dynamic redistribution pattern mirrors that of PLK1, though with subtle spatial differences, providing important insights into centromeric signaling networks.

How does RSF1 coordinate with PLK1 and Aurora B during mitosis?

RSF1 participates in a sophisticated spatiotemporal coordination network with PLK1 and Aurora B kinases during mitotic progression. Recent studies have elucidated that the RSF1-PLK1 axis functions as a critical regulatory mechanism that spatiotemporally controls Aurora B kinase activity . This coordination is essential for proper chromosome segregation and cell division. During mitosis, RSF1 exhibits dynamic positional changes that parallel those of PLK1, with both proteins redistributing from centromeres to kinetochores depending on microtubule attachment status .

In nocodazole-arrested cells (lacking microtubule attachment), RSF1 aligns adjacent to Aurora B at the centromere, though maintaining a distinct position compared to PLK1, which positions slightly further from Aurora B than RSF1 . Conversely, in paclitaxel-arrested cells (with stabilized microtubule attachments), RSF1 redistributes to form two distinct spots separated by centromeric Aurora B, mimicking PLK1's arrangement . This positional choreography likely facilitates tension sensing and error correction mechanisms during chromosome alignment, highlighting RSF1's role beyond chromatin remodeling to include mitotic regulation.

What computational approaches can enhance epitope prediction for RSF1 antibody development?

Recent advances in computational structural modeling offer powerful new approaches to antibody epitope prediction and clustering. The SPACE (Structural Profiling of Antibodies to Cluster by Epitope) algorithm represents a cutting-edge computational method that clusters antibodies targeting the same epitope based on their predicted 3D structures . While not specifically developed for RSF1 antibodies, this approach demonstrates how structural comparisons can provide insights beyond traditional sequence-based clonotyping methods.

The SPACE algorithm works by:

• Creating homology models of antibody variable domains

• Clustering antibodies first by CDR lengths

• Further grouping by structural root-mean-square deviation (RMSD) between CDR templates

• Identifying structural clusters that likely target the same epitope

Applied to coronavirus antibodies, this approach revealed that 92% of multiple-occupancy structural clusters contained antibodies binding to consistent antigen domains, despite sequence dissimilarity . For RSF1 antibody development, such computational approaches could identify structurally similar antibodies with diverse sequences that target the same epitope region, potentially enhancing both specificity and diversity of available research tools.

How can researchers validate epitope specificity of RSF1 antibodies?

Validating epitope specificity for RSF1 antibodies requires a multi-faceted approach that combines computational prediction with experimental verification. Based on structural modeling approaches described in antibody research, researchers should:

• Employ epitope mapping techniques:

  • Peptide arrays covering the RSF1 sequence

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS)

  • Mutagenesis of predicted epitope residues followed by binding studies

• Validate using knockout/knockdown controls:

  • CRISPR/Cas9-mediated RSF1 knockout cells

  • siRNA knockdown with recovery experiments using epitope-mutated constructs

• Assess cross-reactivity:

  • Test against related proteins in the same family

  • Evaluate binding to orthologous proteins from different species

• Confirm functional relevance:

  • Determine if antibody binding affects RSF1's interaction with chromatin or other proteins

  • Assess impact on ATPase stimulation of SMARCA1/SMARCA5

Data from structural studies indicate that antibodies with as little as 43% sequence identity in their CDRH3 regions can bind to the same epitope with similar binding modes . This suggests that epitope validation should not rely solely on sequence similarity but should incorporate structural and functional assessments for comprehensive characterization.

What factors contribute to variability in RSF1 detection across different cell types?

Researchers frequently encounter variability in RSF1 detection across different cell types and experimental conditions. Several key factors contribute to this variability:

• Cell cycle-dependent expression and localization:

  • RSF1 exhibits dynamic redistribution between centromeres and kinetochores during mitosis

  • Expression levels may fluctuate throughout the cell cycle

• Post-translational modifications:

  • Phosphorylation states may affect epitope accessibility

  • Other modifications may alter protein conformation

• Protein complex formation:

  • RSF1 exists in different complexes (RSF-1 and RSF-5) that may mask epitopes

  • Interaction with histone H3, Aurora B, or BubR1 depends on cellular conditions

• Technical considerations:

  • Fixation methods affect epitope preservation differently across cell types

  • Permeabilization conditions impact antibody accessibility to nuclear targets

To address these variables, researchers should standardize cell synchronization protocols, include appropriate controls for each cell type, and validate detection methods using multiple antibody clones targeting different RSF1 epitopes. Western blotting should complement immunofluorescence studies to confirm expression levels separate from localization patterns.

How can researchers resolve contradictory results when studying RSF1 functions?

When facing contradictory results in RSF1 functional studies, researchers should systematically evaluate several potential sources of discrepancy:

• Experimental timing considerations:

  • RSF1 exhibits dynamic localization patterns that change rapidly during mitosis

  • Cell synchronization methods may capture different temporal windows

• Context-dependent protein interactions:

  • RSF1 associates with different partners depending on microtubule attachment status

  • Chromatin state affects RSF1 binding and function

• Antibody-specific limitations:

  • Different antibody clones may recognize distinct conformational states

  • Some antibodies may interfere with protein function upon binding

• Cell type-specific regulatory mechanisms:

  • Expression of RSF1 partners (SMARCA1/SMARCA5) may vary between cell types

  • Post-translational modification patterns differ across cellular contexts

Resolution strategies should include side-by-side comparison of experimental conditions, use of multiple antibody clones, genetic validation approaches (CRISPR/RNAi), and careful documentation of cell cycle phases. When possible, employing orthogonal detection methods and conducting rescue experiments with wild-type RSF1 in knockdown backgrounds can help clarify contradictory findings.

What are the latest findings on RSF1's role in DNA damage response?

Recent studies have expanded our understanding of RSF1's functions beyond chromatin remodeling to include critical roles in DNA damage response pathways. RSF1 facilitates access to DNA during repair processes through its ability to form ordered nucleosome arrays on chromatin . This function is particularly important during double-strand break repair, where chromatin accessibility must be precisely regulated.

The RSF1-containing chromatin remodeling complexes work in concert with other DNA repair factors to coordinate the recruitment of repair machinery to damage sites. Although the search results don't provide specific details on RSF1's DNA damage response functions, related literature indicates that RSF1 influences ATM-dependent signaling and homologous recombination efficiency. Further research is needed to fully elucidate the molecular mechanisms through which RSF1 contributes to genome stability maintenance and DNA repair pathway choice.

How is RSF1 being investigated in cancer research contexts?

RSF1's chromatin remodeling functions position it as a potentially significant factor in cancer development and progression. While the provided search results don't explicitly discuss cancer research applications, the protein's fundamental roles in chromatin organization, cell cycle regulation, and DNA repair suggest several important research directions:

• Expression analysis in cancer tissues:

  • Using validated RSF1 antibodies for IHC-P to assess correlation with clinical outcomes

  • Evaluating RSF1 as a potential diagnostic or prognostic biomarker

• Functional studies in cancer models:

  • Investigating how RSF1 overexpression or deficiency affects genomic stability

  • Examining interactions with known oncogenes and tumor suppressors

• Therapeutic targeting approaches:

  • Exploring RSF1-containing complexes as potential drug targets

  • Developing methods to modulate RSF1 activity in cancer cells

Research into RSF1's spatiotemporal coordination with PLK1 and Aurora B is particularly relevant to cancer contexts, as these mitotic kinases are frequently dysregulated in malignancies . Understanding how RSF1 influences chromosome segregation and cell division could reveal new insights into chromosomal instability in cancer.